National Vaccine Advisory Committee, Subcommittee on Future Vaccines, Subcommittee on Immunization Coverage, and Subcommittee on Vaccine Safety and Communication Meetings

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following Federal advisory committee meetings.

Name: National Vaccine Advisory Committee (NVAC).

Times and Dates: 9 a.m.-2:15 p.m., May 22, 2000; 8:30 a.m.-12:45 p.m., May 23, 2000.

Place: Hubert H. Humphrey Building, Room 505A, 200 Independence Avenue, SW, Washington, DC 20201.

Status: Open to the public, limited only by the space available.

Notice: In the interest of security, the Department has instituted stringent procedures for entrance to the Hubert H. Humphrey Building by non-government employees. Thus, persons without a government identification card should plan to arrive at the building each day either between 8:00 a.m. and 8:30 a.m. or 12:30 p.m. and 1:00 p.m. Entrance to the meeting at other times during the day cannot be assured.

Purpose: This committee advises and makes recommendations to the Director of the National Vaccine Program on matters related to the Program responsibilities.

Matters to be Discussed: Agenda items will include: an update on the National Vaccine Program Office (NVPO) activities; an update on Unmet Needs Funding; Influenza Vaccine—New Technologies; Pandemic Planning and Adult Immunization; Bioterrorism—Advisory Committee on Immunization Practices (ACIP)/NVAC Activities; Large Population Immunization; Immunization Registries Funding Issues; Vaccine Safety and Communication Subcommittee Report; update from the Office of the Assistant Secretary for Health and Surgeon General; Immunization Coverage Subcommittee Report; Future Vaccines Subcommittee Report; ACIP Annual Report; a report on NVAC Poliovirus Containment Workgroup; Together for Tots/Preventive Services Collaborative.

Name: Subcommittee on Future Vaccines.

Time and Date: 2:15 p.m.-5 p.m., May 22, 2000.

Place: Hubert H. Humphrey Building, Room 305A, 200 Independence Avenue, SW, Washington, DC 20201.

Status: Open to the public, limited only by the space available.

Purpose: This subcommittee develops policy options and guides national activities that lead to accelerated development, licensure, and the best use of new vaccines in the simplest possible immunization schedules.

Matters to be Discussed: Agenda items will include discussions on the Institute of Medicine Report “Vaccines for the 21st Century” Cytomegalovirus (CMV) Workshop planned meeting; Vaccines for Chronic diseases meeting.

Name: Subcommittee on Immunization Coverage.

Time and Date: 2:15 p.m.-5 p.m., May 22, 2000.

Place: Hubert H. Humphrey Building, Room 505A, 200 Independence Avenue, SW, Washington, DC 20201.

Status: Open to the public, limited only by the space available.

Purpose: This subcommittee will identify and propose solutions that provide a multifaceted and holistic approach to reducing barriers that result in low immunization coverage for children.

Matters to be Discussed: Agenda items will include adolescent immunization coverage rates; review of the Adult Immunization Standards' document; immunization requirements for school entry and philosophical exemptions; update on unmet needs; the roll-out process for the “Strategies to Sustain Success” and the Adult Immunization Action Plan.

Name: Subcommittee on Vaccine Safety and Communication.

Time and Date: 2:15 p.m.-5 p.m., May 22, 2000.

Place: Hubert H. Humphrey Building, Room 325A, 200 Independence Avenue, SW, Washington, DC 20201.

Status: Open to the public, limited only by the space available.

Purpose: This subcommittee reviews issues relevant to vaccine safety and adverse reactions to vaccines.

Matters to be Discussed: Communication Workshop; Vaccine Safety Surveillance; and Standards for Pediatric Immunization Practices.

Agenda items are subject to change as priorities dictate.

Contact Person for More Information: Gloria Sagar, Committee Management Specialist, NVPO, CDC, 1600 Clifton Road, NE, M/S D-66, Atlanta, Georgia 30333, telephone 404/687-6672.

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.